User profiles for Charles Truillet
Charles TruilletScientist at CEA Verified email at cea.fr Cited by 2306 |
68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience
TA Hope, C Truillet, EC Ehman… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The purpose of this work was to evaluate the effect of androgen receptor (AR) inhibition on
prostate-specific membrane antigen (PSMA) uptake imaged using 68 Ga-PSMA-11 PET in a …
prostate-specific membrane antigen (PSMA) uptake imaged using 68 Ga-PSMA-11 PET in a …
Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection
L Sancey, S Kotb, C Truillet, F Appaix, A Marais… - ACS …, 2015 - ACS Publications
We previously reported the synthesis of gadolinium-based nanoparticles (NPs) denoted
AGuIX (activation and guiding of irradiation by X-ray) NPs and demonstrated their potential as …
AGuIX (activation and guiding of irradiation by X-ray) NPs and demonstrated their potential as …
A Top‐Down synthesis route to ultrasmall multifunctional Gd‐Based silica nanoparticles for theranostic applications
A Mignot, C Truillet, F Lux, L Sancey… - … A European Journal, 2013 - Wiley Online Library
New, ultrasmall nanoparticles with sizes below 5 nm have been obtained. These small rigid
platforms (SRP) are composed of a polysiloxane matrix with DOTAGA (1,4,7,10‐…
platforms (SRP) are composed of a polysiloxane matrix with DOTAGA (1,4,7,10‐…
AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine
…, S Dufort, F Rossetti, M Martini, C Truillet… - The British journal of …, 2019 - birpublications.org
AGuIX ® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium
chelates. This nanoparticle has been recently accepted in clinical trials in association with …
chelates. This nanoparticle has been recently accepted in clinical trials in association with …
Imaging PD-L1 expression with immunoPET
C Truillet, HLJ Oh, SP Yeo, CY Lee… - Bioconjugate …, 2018 - ACS Publications
High sensitivity imaging tools could provide a more holistic view of target antigen expression
to improve the identification of patients who might benefit from cancer immunotherapy. We …
to improve the identification of patients who might benefit from cancer immunotherapy. We …
Development of a stress response therapy targeting aggressive prostate cancer
Oncogenic lesions up-regulate bioenergetically demanding cellular processes, such as protein
synthesis, to drive cancer cell growth and continued proliferation. However, the hijacking …
synthesis, to drive cancer cell growth and continued proliferation. However, the hijacking …
X-ray-induced singlet oxygen activation with nanoscintillator-coupled porphyrins
AL Bulin, C Truillet, R Chouikrat, F Lux… - The Journal of …, 2013 - ACS Publications
Tb 2 O 3 coated with a polysiloxane layer is a biocompatible nanoscintillator that exhibits an
appropriate pattern of biodistribution after injection. In this contribution, we combine this …
appropriate pattern of biodistribution after injection. In this contribution, we combine this …
[HTML][HTML] Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
…, S Dufort, E Brauer, A Marais, C Truillet… - Cancer …, 2014 - Springer
AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates.
They present several characteristics. They are easy to produce, they present very small …
They present several characteristics. They are easy to produce, they present very small …
Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
While there have been tremendous efforts to target oncogenic RAS signaling from inside
the cell, little effort has focused on the cell-surface. Here, we used quantitative surface …
the cell, little effort has focused on the cell-surface. Here, we used quantitative surface …
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
…, JJ Liu, CL Amling, C Truillet… - Genes & …, 2017 - genesdev.cshlp.org
There is limited knowledge about the metabolic reprogramming induced by cancer therapies
and how this contributes to therapeutic resistance. Here we show that although inhibition of …
and how this contributes to therapeutic resistance. Here we show that although inhibition of …